Adamas Pharma (ADMS) – Hot FDA News
-
UPDATE: NIH Says Researchers Identify Potential New Antiviral Drug For Covid-19 - Reuters (ADMP)
-
Adamas Pharma (ADMS) Announces FDA Approval for Second Indication for GOCOVRI as Adjunctive Treatment to levodopa/carbidopa in Parkinson’s Disease Patients Experiencing OFF Episodes
-
-
-
-
-
Back to ADMS Stock Lookup